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Conclusions: 1) The symptom profile with suboptimal fundoplication poorly 
parallels observed functional abnormalities, 2) In every case, symptomatic 
fundoplications could be characterized by one or more functional abnormality 
of either position, movement, or transit across the gastroesophageal junction, 
3) Standard methods of symptom assessment are deceiving in the post- 
surgical evaluation of fundoplication. 
G0472 
INTERACTION OF HELICOBACTER PYLORI (H.p.) EXTRACTS 
WITH BASIC FIBROBLAST GROWTH FACTOR (bFGF): 
SUSPENSION OF H.p. BUT NOT FILTRATE INTERACTS WITH 
bFGF AND DECREASES CELL MIGRATION. H. Ernst, S. Winkler, A. 
Foryst, K. Vogt*, H. Lochs Depts. of Medicine IV and Microbiology*, 
Charit6, Berlin, Germany 
Baek~,round: H.p. predisposes to peptic ulcer disease, bFGF is able to 
stimulate the migration of epithelial cells during wound healing and is 
localized in epithelial cells, in basement membranes and the extracellular 
matrix. Recent findings suggest that H.p. might interfere with the activation 
of bFGF from extracellular matrix. Here we determined the effect of H.p. 
suspension or H.p. filtrate and addition of bFGF on cell migration 
Method: Monolayers of intestinal epithelial cells (IEC-6) were wounded with 
a razor blade (3 separate wounds per dish). The wounded monolayers were 
incubated for 24h with serial dilutions of H.p. suspension (NCTC 11637) 
(2x107 bacteria/ml and 4.5 ng/ml bFGF; lxl07 bacteria/ml and 4.5 ng/ml 
bFGF), filtrate (2x107 bacteria/ml passed through a 0.2 mm filter and 4.5 
ng/ml bFGF; lxl07 bacteria/ml passed through a 0.2 mm filter and 4.5 ng/ml 
bFGF), serumfree medium with bFGF (4.5 ng/ml bFGF) (control) or 
serumfree medium (control). The number of IEC-6 cells observed across the 
wound border in a standardized wound area was assessed in a blinded fashion. 
At least nine wounds per group were assessed. 
Results: The mean number of migrated cells/standard wound per group was 
decreased by addition of H.p. suspension (2x107 bacteria/ml) to bFGF (4.5 
ng/ml bFGF) (8.3 -+ 2.2, mean _+ SEM) compared to addition of bFGF (4.5 
ng/ml bFGF) alone (15.5 -+ 3.4). Differences were at the border of statistical 
significance. Incubation of bFGF with filtrate of H.p. did not decrease cell 
migration. 
Conclusion: Suspension but not filtrate of H.p. decreases the effect bFGF on 
cell migration. Products of damaged H.p. may impair the physiological 
process of cell migration via interaction with bFGF. 
• G0473 
SINGLE EXPOSURE OF WOUNDED CELL MONOLAYER TO 
EXTRACTS OF HELICOBACTER PYLORI (H.p.) BUT NOT OF 
COCULTURE WITH LIVING H.p. DECREASES CELL MIGRATION 
VIA A REDUCED EXPRESSION OF TGF[31. H. Ernst. S. Winkler, A. 
Foryst, K. Vogt*, H. Lochs. Depts. of Medicine IV and Microbiology*, 
CharitY, Berlin, Germany 
Backeround: H.p. predisposes to peptic ulcer disease. The mechanism by 
which H.p. produces these effects is unclear. H.p. may impair the process of 
gastric mucosal repair. Cell migration, cell proliferation and expression of 
TGF[31 play a key role in wound healing. Here we determined the effect of 
H.p. suspension, H.p. filtrate or coculture with H.p. on cell migration and 
assessed the expression of TGF[~I by quantitative mimic RT-PCR. Method: 
Monolayers of intestinal epithelial cells (IEC-6) were wounded with a razor 
blade (3 separate wounds per dish). The wounded monolayers were incubated 
for 24h with serial dilutions of H.p. suspension (NCTC 11637) (6xl0Scfu/ml), 
H.p. filtrate (6xl08cfu/ml), C. jejuni filtrate or suspension (6xl08cfu/ml), 
LPS, coculture with H.p. or serumfree medium (control). The number of 
IEC-6 cells observed across the wound border in a standardized wound area 
was assessed in a blinded fashion. Experiments were performed in triplicate. 
The effect of bacterial suspension or filtrate on cell proliferation was assessed 
using Cell Titer 96®AQueous kit from Promega. Expression and quantitation 
of TGF[31 and [3- Actin mRNA was assessed using competitive mimic RT- 
PCR. Results: The mean number of migrated cells/standard wound per group 
was decreased by addition of H.p. filtrate (26 _+ 6.6[SEM] vs control 42 -+ 8.1; 
p < 0.05) or suspension (37 + 8 vs control 42 + 8.1; p < 0.05). Addition of 
suspension or filtrate of C. jejuni or LPS in different doses (15 x 10 -5 g/petti 
dish to 0.46 x 10-Sg/petri dish) did not decrease cell migration. After coculture 
with living H.p. there was no statistical significant decrease (91 +-12 vs 
control 86.5 -+ 12.6) of ceil migration. Cell proliferation was not affected by 
24 h incubation with suspension or filtrate of H.p.. Expression of [~-actin was 
constant in all groups (3.3 attomole/~g RNA) and expression of TGF[31 was 
50% of control value (2.xl0"2attomole/pg RNA vs control 4xl0-2attomole/IJg 
RNA) after incubation with filtrate and 12.5% to 50% of control 
value(0.5xl0-2attomole/~g RNA; 2.xl0-2attomole/~g RNA vs control 4xl0- 
2attomole/~g RNA) after incubation with serial dilutions of H.p. suspension. 
Conclusion: Suspension or filtrate of H.p. decrease cell migration via reduced 
expression of TGF[31. LPS or coculture of Hp. does not decrease cell 
migration. Products of damaged H.p. may impair the physiological process of 
cell migration. 
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PANTOPRAZOLE 40 MG AND 20 MG ARE EQUIVALENT IN PREVEN- 
TION OF RELAPSE OF REFLUX ESOPHAGITIS. J. Escourrou. R. Fiasse, § 
A. Saggioro, ~ D. Vaira, # H. Geldof, 1 R. Fischer,* C. Maier.* CHU Toulouse 
Ranqueil, Toulouse, France; § UCL Cliniques St Luc, Brussels, Belgium; 
Ospedale Umberto I, Mestre, Italy; #Ospedale S. Orsola, Bologna, Italy; ~I 
Ijsselland Ziekenhuis, Capelle, Netherlands and *Byk Gulden, Constance, 
Germany. 
AIM: To compare the efficacy and tolerability of pantoprazole (PAN) 40 mg 
and 20 mg as a relapse prophylaxis over 1 year for reflux esophagitis patients 
previously healed with PAN or omeprazole (OME). 
METHODS: Patients with reflux esophagitis (GERD) Savary/Miller stage II 
or III previously healed on PAN 40 mg or OME 20 mg for 4-8 weeks in a 
multi-center study in Belgium, France, Italy and the Netherlands were 
randomised to receive, double-blind, either 20 mg or 40 mg PAN once daily 
for up to 1 year. Follow-up visits were performed every 3 months with 
endoscopies at 6 and 12 months or when patients perceived GERD symptoms 
on at least 3 consecutive days. The primary parameter was time until 
endoscopically proven relapse of GERD and secondary parameters were time 
until symptomatic relapse, laboratory values and adverse events (AE). 
RESULTS: 396 patients were included in this study with 203 receiving 20 
mg PAN and 193 receiving 40 mg PAN. Estimated endoscopic relapse rates at 
6 and 12 months were 16% and 28% respectively for the 20 mg group, and 
7% and 19% respectively for the 40 mg group (Kaplan-Meier). Based on the 
90% CI of the difference in the 12 month relapse rate, therapeutic equivalence 
of 20 mg and 40 mg PAN was concluded (equivalence range:-+ 20%). 
Symptomatic relapse rates at 12 months were 21% and 17% for the 20 mg and 
40 mg groups respectively and these were also therapeutically equivalent 
using the same approach as above. AE were reported by 97/396 patients 
(24%): 33 were considered by the investigators to be possibly related to study 
medication and 2 (substernal chest pain and diarrhea) to be definitely related. 
The percentage of patients reporting AE were similar in the two groups. The 
most common AE considered possibly or definitely related to PAN were 
increase in SGPT (2%), increase in SGOT (1%), diarrhea (1%), and 
abdominal pain (1%). Fourteen serious AE were reported in 14 patients, of 
which 3 led to premature study discontinuation. Only isolated changes in 
clinical laboratory values in some patients were observed throughout the 
study. Serum gastrin increased slightly but without clinical relevance. 
CONCLUSIONS: Pantoprazole 20 mg and 40 mg are therapeutically 
equivalent and well-tolerated in prevention of endoscopic and symptomatic 
recurrence of reflux esophagitis. 
This study was sponsored by Nycomed and Byk Gulden. 
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LACK OF BIOCHEMICAL CORRELATION BETWEEN THE 
PROTECTIVE EFFECT OF PROSTAGLANDINS AND NITRIC OXIDE 
PATHWAY ON NSAID-INDUCED GASTRIC INJURY. J. Esteban 1, J.M. 
Herrerias Jr. 2, M.M. Espinosa 1, J.A. Martin, M.A. Rodrfguez l, V. Motilva 2, 
C. Alarc6n 2, M.J. Martin 2, P. Hergueta 2 and J.M. Herrerfas 2. 1- Servicio 
Central de Investigaci6n en Ciencias de la Salud. Universidad de C~idiz. 
Spain. 2- Servicio de Aparato Digestivo. Hospital Universitario Virgen 
Macarena. Sevilla. Spain. 
In recent reports we have proved that NSAIDs induce a doses-dependent 
decrease in cGMP concentraci6n in gastric mucosa. We have also shown that 
the use of phosphodiesterase inhbitors prevents NSAID-induced gastric 
toxicity. On the other hand, prostaglandins have a protective activity on 
NSAID-induced gastric injury. Besides, the induced biochemical actions can 
be superposed to those induced by NO and its second messenger, cGMP, on 
gastric mucosa. For this reason we can deduce that there may be a relation 
between these systems. In order to check this possibility we have investigated 
the interaction between misoprostol (200 mcg/Kg, p.o.) and ODQ (selective 
inhibitor of the nitric oxide dependent guanyl-cyclase) (3 mg/Kg, s.c.) on 
gastric injuries induced by the administration of aspirin (100, 300 and 500 
mg/Kg, p.o.). Three hours after NSAID administration the animal is 
anesthetized, the stomach removed and the aspirin-induced gastric erosions 
measured in mm 2. The mucosa is scraped and frozen at -80°C until the later 
cGMP determination by RIA. The quantity of proteins is determined by 
means of Lowry method. The results show that ODQ does not induce gastric 
injury alone, but increases the gastric toxicity of aspirin. On the contrary, it 
does not modify the protective effect of misoprostol on aspirin-induced 
gastric injury. Both, ODQ and aspirin administration decrease the cGMP 
concentration in gastrin mucosa (in a greater degree when associated). 
However, mis0prostol administration does not modify the cGMP intragastric 
concentration when it is administered neither alone, together with ODQ, 
aspirin or in association with both of them. As a conclusion we can say that 
the protective mechanisms mediated by NO or by prostaglandins seem to be 
independent. Moreover, cGMP does not seem to mediate the aspirin-induce 
gastric damage, but it does participate in later regeneration mechanisms. 
